$2.14
At close: Oct 11, 5:00 PM EST
$0.3500
-1.79-83.64%
After Hours: Jan 27, 4:01 PM EST
EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. Earnings Estimates
EGRXOTCEM
EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. Earnings Estimates, EPS & Revenue | OTC:EGRX
In the most recent quarter (Q2), EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. reported EPS of $1.18, beating estimates of $1.05 by 0.12%. Revenue came in at $64.65M, exceeding the estimate of $59.35M by 0.09%.
EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. has beaten EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. has averaged an EPS surprise of 0.22% and a revenue surprise of 0.06%.
Earnings Date
Aug 8
EPS
$1.180
Quarterly Revenue
$64.65M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$257.55M
EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. Earnings History
Analyze the earnings history of EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. using advanced sorting and filters.
Loading calendar...
EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (EGRX) Earnings Per Share
The chart below shows EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc.'s reported EPS compared to analyst estimates over recent quarters.
EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (EGRX) Revenue
The chart below shows EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc.'s reported revenue compared to analyst estimates over recent quarters.
FAQ
When is EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (OTCEM:EGRX) reporting earnings?
EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (EGRX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on August 8, 2023 for Q2.
What were the latest earnings per share (EPS) for EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (OTCEM:EGRX)?
EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (EGRX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on August 8, 2023 for Q2 and the Actual EPS was $1.18, which beat the estimate of $1.05.
What were EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc.’s (OTCEM:EGRX) revenues?
EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (EGRX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on August 8, 2023 for Q2 and the Actual Revenue was $64.65M, which beat the estimate of $59.35M.
